Using ultrasound to detect nerve changes in GBS and CIDP
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests if ultrasound can find nerve problems in people with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), and if it helps doctors diagnose and predict outcomes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 75 years
- Diagnosed with GBS within the last 2 weeks, or diagnosed with CIDP (relapsing or progressive type)
- Willing to undergo exams and assessments for the study
- Able and willing to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to look at the nerves in children with Guillain-Barré syndrome, a condition that causes weakness. It aims to see if ultrasound can help doctors understand or monitor the disease.
This study uses a special ultrasound to look at your nerves to better understand peripheral neuropathy (nerve damage). It aims to improve diagnosis and treatment planning without any surgery or needles.
This study uses an ultrasound scan to look at muscles and nerves (including the breathing muscle). It may help researchers better understand neuromuscular problems and how well ultrasound can detect them.
This trial tests whether an experimental drug called efgartigimod (given as an infusion) can help people with Guillain-Barré syndrome recover faster. It is for adults who recently developed symptoms and have significant weakness that affects their walking.
This study uses nerve tests and ultrasound to look at how diabetes affects nerves and the body's automatic functions. It may help doctors better understand and detect nerve damage from diabetes.
This study uses ultrasound to look at nerves in people with CIDP to help guide treatment. It aims to see if ultrasound can help doctors choose the best therapy for each person.
Hear when a new Guillain Barré Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.